NASDAQ · DMIIR
Drugs Made In America Acquisition II Corp. Right
Financial Services · Asset Management
$0.06
Down-$0.01 (-7.98%)
Updated Sep 26, 2026, 8:45 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 10.16M
- P/E ratio
- -54.87
- Dividend yield
- 0.00%
- 52-week range
- $0.06 – $0.11
- Volume
- 101.73K
- Avg. volume
- 776.48K
Price performance
DMIIR price history
1M range · 13 trading sessions · Daily adjusted prices
DMIIR closed at $0.06 after 13 trading sessions, down 24.05% for the selected period.
- Last close
- $0.06
- Period change
- -24.05%
- Period low
- $0.06
- Period high
- $0.08
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $0.0611 | $0.0611 | $0.0595 | $0.06 | 101.73K |
| Sep 24, 2026 | $0.066 | $0.066 | $0.065 | $0.0652 | 7.6K |
| Sep 23, 2026 | $0.0681 | $0.0681 | $0.0681 | $0.0681 | 500 |
| Sep 22, 2026 | $0.07 | $0.077 | $0.066 | $0.0661 | 214.41K |
| Sep 21, 2026 | $0.066 | $0.071 | $0.066 | $0.071 | 1.41K |
| Sep 16, 2026 | $0.075 | $0.075 | $0.075 | $0.075 | 1.01K |
| Sep 14, 2026 | $0.0925 | $0.0936 | $0.0651 | $0.0749 | 11.44K |
| Sep 11, 2026 | $0.093 | $0.0987 | $0.08 | $0.08 | 7.56K |
| Sep 10, 2026 | $0.0721 | $0.0721 | $0.0699 | $0.0699 | 14.33K |
| Sep 8, 2026 | $0.0602 | $0.0801 | $0.0602 | $0.0702 | 7.34K |
| Sep 4, 2026 | $0.08 | $0.08 | $0.0799 | $0.0799 | 449 |
| Sep 2, 2026 | $0.0978 | $0.0978 | $0.07 | $0.07 | 22.5K |
| Sep 1, 2026 | $0.08 | $0.08 | $0.0751 | $0.079 | 60.25K |
Latest DMIIR news
The latest Smart Investors Daily articles mentioning DMIIR.
Stock researchCompany · Overview
DMIIR research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
